34637-22-4 Usage
General Description
Benzyl N-(3-hydroxypropyl)carbamate is a chemical compound that consists of a benzyl group attached to a carbamate functional group, which in turn is linked to a 3-hydroxypropyl group. It is commonly used as a reagent in organic synthesis and as a pharmaceutical intermediate. BENZYL N-(3-HYDROXYPROPYL)CARBAMATE has potential applications in the field of medicinal chemistry, particularly as a precursor for the synthesis of potential drug candidates. Additionally, benzyl N-(3-hydroxypropyl)carbamate may also have applications in the development of new materials and polymers due to its unique chemical structure. As with any chemical compound, proper handling and safety precautions should be taken when working with benzyl N-(3-hydroxypropyl)carbamate.
Check Digit Verification of cas no
The CAS Registry Mumber 34637-22-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,6,3 and 7 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 34637-22:
(7*3)+(6*4)+(5*6)+(4*3)+(3*7)+(2*2)+(1*2)=114
114 % 10 = 4
So 34637-22-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H15NO3/c13-8-4-7-12-11(14)15-9-10-5-2-1-3-6-10/h1-3,5-6,13H,4,7-9H2,(H,12,14)
34637-22-4Relevant articles and documents
A synthesis of tiruchanduramine and a reinvestigation of its glycosidase inhibitory activity
Buck, Matthew L.,Evans, Daniel M.,Evans, Victoria A.,Herkt, Dominik,Sharp, Hazel,Hollinshead, Jackie,Mitschang, Fabian,Murphy, Patrick J.,Nash, Robert J.,Wenbourne, Jack
, p. 4545 - 4548 (2017)
Tiruchanduramine 1 was prepared using a convergent strategy with the longest linear sequence being eight steps. Synthetic 1, displayed a broader range of inhibition than reported previously and, in addition to α-glucosidases, 1 also inhibits almond β-gluc
METHOD FOR PRODUCING (2S)-2-[(1H-PYRAZOL-1-YL)METHYL]-1,3-OXAZINANE DERIVATIVE
-
Paragraph 0290-0292, (2021/05/21)
Provided is a novel process for producing a (2S)-2-[(1H-pyrazol-1-yl)methyl]-1,3-oxazinane derivative. More specifically, provided is a process for producing a (2S)-2-[(1H-pyrazol-1-yl)methyl]-1,3-oxazinane derivative represented by formula (1): the process comprising reacting 3-aminopropan-1-ol with glyoxylic acid.
LOW CONTAMINANT ANTIMICROBIAL VACCINES
-
Paragraph 0081; 0093, (2021/05/21)
Disclosed are antimicrobial vaccines comprising oligosaccharide β-(1→6)-glucosamine groups.